These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20160358)

  • 61. Does cell-of-origin or MYC, BCL2 or BCL6 translocation status provide prognostic information beyond the International Prognostic Index score in patients with diffuse large B-cell lymphoma treated with rituximab and chemotherapy? A systematic review.
    Schmidt-Hansen M; Berendse S; Marafioti T; McNamara C
    Leuk Lymphoma; 2017 Oct; 58(10):2403-2418. PubMed ID: 28278726
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications.
    Ueda C; Akasaka T; Ohno H
    Leuk Lymphoma; 2002 Jul; 43(7):1375-81. PubMed ID: 12389616
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Presence of simian virus 40 in diffuse large B-cell lymphomas in Tunisia correlates with germinal center B-cell immunophenotype, t(14;18) translocation, and P53 accumulation.
    Amara K; Trimeche M; Ziadi S; Laatiri A; Mestiri S; Sriha B; Mokni M; Korbi S
    Mod Pathol; 2008 Mar; 21(3):282-96. PubMed ID: 18165800
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Prognostic evaluation of P53 and BCL2 proteins in MYC/BCL2 double expression DLBCL].
    Huang P; Chen S; Yang X; Lei YY; Xu XY; Liu YX; Guo YH; Pan Y; Wang XH; Zhang HL; Fu K; Meng B
    Zhonghua Xue Ye Xue Za Zhi; 2019 Jul; 40(7):589-593. PubMed ID: 32397023
    [No Abstract]   [Full Text] [Related]  

  • 65. PD1 and PDL1 expression in primary central nervous system diffuse large B-cell lymphoma are frequent and expression of PD1 predicts poor survival.
    Four M; Cacheux V; Tempier A; Platero D; Fabbro M; Marin G; Leventoux N; Rigau V; Costes-Martineau V; Szablewski V
    Hematol Oncol; 2017 Dec; 35(4):487-496. PubMed ID: 27966264
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of the t(14;18) BCL2-IGH translocation in farmers occupationally exposed to pesticides.
    Roulland S; Lebailly P; Lecluse Y; Briand M; Pottier D; Gauduchon P
    Cancer Res; 2004 Mar; 64(6):2264-9. PubMed ID: 15026372
    [TBL] [Abstract][Full Text] [Related]  

  • 67. BCL2 overexpression associated with chromosomal amplification in diffuse large B-cell lymphoma.
    Monni O; Joensuu H; Franssila K; Klefstrom J; Alitalo K; Knuutila S
    Blood; 1997 Aug; 90(3):1168-74. PubMed ID: 9242549
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Prognostic markers and gene abnormalities in subgroups of diffuse large B-cell lymphoma: single center experience.
    Korać P; Dominis M
    Croat Med J; 2008 Oct; 49(5):618-24. PubMed ID: 18925695
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Effect of P53 Expression on Prognosis of Patients with Double Expressor Lymphoma].
    Ding X; Hou SL; Li YQ; Li X; Li L; Lian K; Wang GG; Wu XB; Zhang ZH; Liu H; Wang YQ; Zhang QH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Oct; 27(5):1504-1514. PubMed ID: 31607305
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic significance of Bcl-2 protein expression and Bcl-2 gene rearrangement in diffuse aggressive non-Hodgkin's lymphoma.
    Gascoyne RD; Adomat SA; Krajewski S; Krajewska M; Horsman DE; Tolcher AW; O'Reilly SE; Hoskins P; Coldman AJ; Reed JC; Connors JM
    Blood; 1997 Jul; 90(1):244-51. PubMed ID: 9207459
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Prominent Dutcher body formation in a case of follicular lymphoma with BCL6 gene rearrangement and intact BCL2 gene.
    Kulbacki E; Rehder C; Wang E
    Am J Hematol; 2010 Mar; 85(3):218-9. PubMed ID: 20069653
    [No Abstract]   [Full Text] [Related]  

  • 72. Del(6)(q22) and BCL6 rearrangements in primary CNS lymphoma are indicators of an aggressive clinical course.
    Cady FM; O'Neill BP; Law ME; Decker PA; Kurtz DM; Giannini C; Porter AB; Kurtin PJ; Johnston PB; Dogan A; Remstein ED
    J Clin Oncol; 2008 Oct; 26(29):4814-9. PubMed ID: 18645192
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Detection and possible prognostic relevance of p53 gene mutations in diffuse large B-cell lymphoma. An analysis of 51 cases and review of the literature.
    Kerbauy FR; Colleoni GW; Saad ST; Regis Silva MR; Correa Alves A; Aguiar KC; Albuquerque DM; Kobarg J; Seixas MT; Kerbauy J
    Leuk Lymphoma; 2004 Oct; 45(10):2071-8. PubMed ID: 15370252
    [TBL] [Abstract][Full Text] [Related]  

  • 74. BCL2 antibodies targeted at different epitopes detect varying levels of protein expression and correlate with frequent gene amplification in diffuse large B-cell lymphoma.
    Kendrick SL; Redd L; Muranyi A; Henricksen LA; Stanislaw S; Smith LM; Perry AM; Fu K; Weisenburger DD; Rosenwald A; Ott G; Gascoyne RD; Jaffe ES; Campo E; Delabie J; Braziel RM; Cook JR; Tubbs RR; Staudt LM; Chan WC; Steidl C; Grogan TM; Rimsza LM
    Hum Pathol; 2014 Oct; 45(10):2144-53. PubMed ID: 25090918
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Lack of prognostic significance of BCL2 and p53 protein overexpression in elderly patients with diffuse large B-cell non-Hodgkin's lymphoma: results from a population-based non-Hodgkin's lymphoma registry.
    Maartense E; Kramer MH; le Cessie S; Kluin-Nelemans JC; Kluin PM; Snijder S; Noordijk EM
    Leuk Lymphoma; 2004 Jan; 45(1):101-7. PubMed ID: 15061204
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A comparative study of molecular characteristics of diffuse large B-cell lymphoma from patients with and without human immunodeficiency virus infection.
    Chao C; Silverberg MJ; Xu L; Chen LH; Castor B; Martínez-Maza O; Abrams DI; Zha HD; Haque R; Said J
    Clin Cancer Res; 2015 Mar; 21(6):1429-37. PubMed ID: 25589617
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Patient age at diagnosis is associated with the molecular characteristics of diffuse large B-cell lymphoma.
    Klapper W; Kreuz M; Kohler CW; Burkhardt B; Szczepanowski M; Salaverria I; Hummel M; Loeffler M; Pellissery S; Woessmann W; Schwänen C; Trümper L; Wessendorf S; Spang R; Hasenclever D; Siebert R;
    Blood; 2012 Feb; 119(8):1882-7. PubMed ID: 22238326
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical and genetic characterization of de novo double-hit B cell precursor leukemia/lymphoma.
    Stratmann JA; von Rose AB; Koschade S; Wendelin K; Köhler F; Heinsch M; Schiller K; Haferlach C; Wattad M; Rieder H; Serve H; Gökbuget N; Steffen B
    Ann Hematol; 2019 Mar; 98(3):647-656. PubMed ID: 30613837
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Roles of syndecan-1, bcl6 and p53 in diagnosis and prognostication of immunoproliferative small intestinal disease.
    Vaiphei K; Kumari N; Sinha SK; Dutta U; Nagi B; Joshi K; Singh K
    World J Gastroenterol; 2006 Jun; 12(22):3602-8. PubMed ID: 16773719
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Translocation of the proto-oncogene Bcl-6 in human glioblastoma multiforme.
    Ruggieri S; Tamma R; Marzullo A; Annese T; Marinaccio C; Errede M; Susca FC; Senetta R; Cassoni P; Vacca A; Albano F; Saracino C; Notarangelo A; Specchia G; Ribatti D; Nico B
    Cancer Lett; 2014 Oct; 353(1):41-51. PubMed ID: 25038272
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.